Special Issue "Nrf2 Signaling Pathway in Cardiovascular Health and Disease"
Deadline for manuscript submissions: closed (30 November 2022) | Viewed by 18166
Interests: vascular remodeling; vascular dysfunction; vein graft failure; cardiac remodeling; cardiac dysfunction; heart failure; vascular stem cells; cell death; cell differentiation; cell reprogramming; protein quality control; transcriptional regulation
Nrf2, a transcription factor, has been extensively studied since it was cloned in 1994. It controls the basal and induced expression of over 1000 genes in cells that can be clustered into several functional categories ranging from redox homeostasis and detoxification to metabolism and protein quality control. The historical view of Nrf2-mediated cellular defense has been challenged by the emerging evidence of Nrf2-mediated cell death, revealing Nrf2-mediated dichotomy in a context-dependent manner in various tissues and organs, including the cardiovascular system.
This Special Issue will examine Nrf2-mediated cardiovascular protection and damage as well as the underlying molecular mechanisms, therapeutic potential of targeting Nrf2 in treating cardiovascular disease, and current gaps and future directions for Nrf2 signaling research in the cardiovascular system.
Dr. Taixing Cui
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- redox signaling
- proteasomal degradation
- cell death
- vascular disease
- heart disease
- drug target